Cirugía
Departament
Javier
Angulo Cuesta
Publicacions en què col·labora amb Javier Angulo Cuesta (16)
2022
-
Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study
Journal of Clinical Medicine, Vol. 11, Núm. 4
-
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study
Journal of Clinical Medicine, Vol. 11, Núm. 13
2021
-
Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients
Scientific Reports, Vol. 11, Núm. 1
2020
-
Clinical benefit of tamsulosin and the hexanic extract of serenoa repens, in combination or as monotherapy, in patients with moderate/severe luts-bph: A subset analysis of the qualiprost study
Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-14
2018
-
Efficacy and safety of a hexanic extract of Serenoa repens (Permixon®) for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH): systematic review and meta-analysis of randomised controlled trials and observational studies
BJU International, Vol. 122, Núm. 6, pp. 1049-1065
2013
-
Análisis de los factores que influyen en la pérdida hemática en la nefrolitotomía percutánea: registro de la Asociación Española de Urología sobre la posición supina
Actas Urologicas Espanolas, Vol. 37, Núm. 9, pp. 527-532
-
Efficacy and tolerability of mirabegron, a β3-adrenoceptor agonist, in patients with overactive bladder: Results from a randomised European-Australian phase 3 trial
European Urology, Vol. 63, Núm. 2, pp. 283-295
-
Efficacy of mirabegron in patients with and without prior antimuscarinic therapy for overactive bladder: A post hoc analysis of a randomized European-Australian Phase 3 trial
BMC Urology, Vol. 13
-
Mirabegron for the treatment of overactive bladder: A prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies
International Journal of Clinical Practice, Vol. 67, Núm. 7, pp. 619-632
-
Treatment of prostate and renal cancer with oral drugs (abiratarone and antiangiogenic agents): Positioning statement from the Spanish Association of Urology
Actas Urologicas Espanolas
2007
-
Efecto del tabaco sobre la evolución de los tumores de vejiga
Actas Urologicas Espanolas, Vol. 31, Núm. 4, pp. 349-354
-
Prevalencia y significado clínico de los cánceres de próstata focales e incidentales
Actas Urologicas Espanolas, Vol. 31, Núm. 8, pp. 819-824
2006
-
Significado de la progresión de PSA tras prostatectomía radical. Resultados preliminares
Actas Urologicas Espanolas, Vol. 30, Núm. 4, pp. 353-358
2005
-
Efecto de polifenoles de la dieta mediterránea sobre la proliferación y mediadores de la invasividad "in vitro" de la línea de cáncer vesical murino MB-49
Actas Urologicas Espanolas, Vol. 29, Núm. 8, pp. 743-749
2000
-
Dolor pelvico cronico: Enfoque multidisciplinario
Revista de la Sociedad Espanola del Dolor, Vol. 7, Núm. 6, pp. 375-389
1999
-
Primary bilateral hydatidosis of the psoas muscle
Journal of Urology, Vol. 161, Núm. 5, pp. 1557-1558